Emergency surgical management for complicated schistosomal massive splenomegaly with portomesenteric thrombosis and bowel ischemia: a case report Authors: Rasheed Altwiher, Ahmad Alzaid, Amir Othman, Yasser Alhabeeb, Mahabbah Fawaz Almarshdi, Yasmin Al-Shammari Published: 2026 ABSTRACT Introduction:Schistosomal periportal fibrosis is a major cause of non-cirrhotic portal hypertension and massive splenomegaly. Rarely, superimposed portomesenteric venous thrombosis (PMVT) may precipitate bowel ischemia. Managing this combination in non-endemic settings presents significant diagnostic and therapeutic challenges. We report successful bowel salvage and definitive portal decompression during the same surgical course.Case presentation:A 43-year-old man with schistosomal periportal fibrosis and massive splenomegaly presented with partial PMVT-associated bowel ischemia. Following surgeon-led MDT evaluation, emergency laparotomy revealed an ischemic jejunal segment, which was completely salvaged after extensive adhesiolysis relieved severe splenic mesenteric traction. Concurrently, splenectomy and esophagogastric devascularization successfully addressed the underlying portal hypertension. After a 48-hour damage-control temporary closure, a second-look confirmed bowel viability. A postoperative Grade B pancreatic fistula resolved conservatively. The patient recovered completely, with long-term variceal regression.Conclusion:Definitive surgical management can complement emergency intervention in selected patients with advanced hepatosplenic schistosomiasis. Successful outcomes require timely surgeon-led multidisciplinary decision-making and careful damage-control surgical planning. Introduction Massive splenomegaly (>20 cm in length or >8 cm below the costal margin) presents a major clinical challenge requiring a surgeon-led multidisciplinary evaluation[1]. In endemic areas, hepatosplenic schistosomiasis drives non-cirrhotic portal hypertension through schistosomal ova deposition and periportal fibrosis, leading to progressive splenomegaly and hypersplenism-induced cytopenias[2–4]. Advanced disease can trigger portomesenteric venous thrombosis (PMVT), exacerbating portal congestion and precipitating variceal hemorrhage or mesenteric ischemia[5]. The synchronous coexistence of massive splenomegaly, severe thrombocytopenia, PMVT, and acute bowel ischemia is exceptionally rare[6,7]. Emergency massive splenectomy is technically demanding due to collateral circulation, dense adhesions, and high risks of hemorrhagic or pancreatic complications[6,7]. We report a unique case managed in a non-endemic setting, highlighting the critical role of surgeon-led multidisciplinary decision-making and the integration of damage-control surgery with definitive portal decompression[2,6,8,9]. HIGHLIGHTSBackground: The report details a rare case of surgical management of massive schistosomal splenomegaly complicated by acute portomesenteric thrombosis and bowel ischemia.Novel findings: These findings highlight the feasibility of “planned last-resort surgery” in high-risk patients with extensive vascular thrombosis, in whom conservative management fails.Key results: Successful splenectomy and vascular control were achieved, with the resected specimen weighing more than 1 kg, leading to clinical stabilization.Clinical relevance: This case emphasizes that aggressive surgical intervention can be life-saving in treating segmental bowel ischemia secondary to schistosomal complications.Validation: The findings were validated through intraoperative confirmation of ischemia and histopathological analysis demonstrating characteristic Gamna-Gandy bodies and features of portal hypertension. HIGHLIGHTS Background: The report details a rare case of surgical management of massive schistosomal splenomegaly complicated by acute portomesenteric thrombosis and bowel ischemia. Background: The report details a rare case of surgical management of massive schistosomal splenomegaly complicated by acute portomesenteric thrombosis and bowel ischemia. Novel findings: These findings highlight the feasibility of “planned last-resort surgery” in high-risk patients with extensive vascular thrombosis, in whom conservative management fails. Novel findings: These findings highlight the feasibility of “planned last-resort surgery” in high-risk patients with extensive vascular thrombosis, in whom conservative management fails. Key results: Successful splenectomy and vascular control were achieved, with the resected specimen weighing more than 1 kg, leading to clinical stabilization. Key results: Successful splenectomy and vascular control were achieved, with the resected specimen weighing more than 1 kg, leading to clinical stabilization. Clinical relevance: This case emphasizes that aggressive surgical intervention can be life-saving in treating segmental bowel ischemia secondary to schistosomal complications. Clinical relevance: This case emphasizes that aggressive surgical intervention can be life-saving in treating segmental bowel ischemia secondary to schistosomal complications. Validation: The findings were validated through intraoperative confirmation of ischemia and histopathological analysis demonstrating characteristic Gamna-Gandy bodies and features of portal hypertension. Validation: The findings were validated through intraoperative confirmation of ischemia and histopathological analysis demonstrating characteristic Gamna-Gandy bodies and features of portal hypertension. Methods This case report has been prepared and reported in strict accordance with the updated SCARE 2025 Guidelines[10]. Case presentation A 43-year-old livestock worker with schistosomal periportal fibrosis, portal hypertension, and a history of variceal bleeding presented with progressive abdominal distension secondary to massive splenomegaly. He reported a 2–3-year history of gradual abdominal enlargement with mild, intermittent epigastric pain. Laboratory investigations demonstrated severe thrombocytopenia and leukopenia consistent with advanced hypersplenism, while hepatic function remained preserved (Child-Pugh A). The relevant laboratory values are summarized in Table 1. An emergency exploratory laparotomy was performed under direct, surgeon-led multidisciplinary team (MDT) leadership. Preoperative preparation included securing six units each of packed red blood cells (PRBCs), fresh frozen plasma (FFP), and platelets. To maximize circulating platelets and prevent immediate splenic entrapment, platelet transfusions were strategically initiated intraoperatively immediately following ligation of the splenic artery. Surgical exploration revealed a dusky, pale 20 cm segment of the jejunum. Crucially, the loop remained viable with positive blanching and active reperfusion. The primary pathology was not mesenteric arterial occlusion, but rather severe mechanical caudal traction on the mesenteric root induced by the physical weight of the giant (20.8 cm) spleen compounded by dense, inflammatory fibrocongestive adhesions (Fig. 1). Meticulous adhesiolysis and splenic mobilization instantly relieved this mechanical stress, returning normal serosal color and ensuring bowel viability. To decompress the portomesenteric system, the team performed a concurrent splenectomy and extensive esophagogastric devascularization, systematically ligating the left gastric, short gastric, posterior gastric, and left gastroepiploic vessels (Figs 2 and 3). To prevent the lethal triad, a strict 60–90-minute damage-control window was enforced. Advanced energy devices were utilized solely for major definitive bleeders, while diffuse venous oozing from the raw perisplenic bed was managed with temporary abdominal packing and a containment closure system. The patient was stabilized in the ICU, where the elimination of splenic sequestration allowed the platelet count to normalize to 336 × 109/L. This rapid hematological correction enabled the safe initiation of therapeutic enoxaparin on postoperative day (POD) 3 to address the portomesenteric thrombosis. At 48 hours, a planned second-look laparotomy successfully confirmed complete subphrenic hemostasis and full intestinal viability, allowing for permanent abdominal closure and Jackson-Pratt (JP) drain placement. On POD 5, an increased subphrenic drain output with a drain-fluid-to-serum-amylase ratio of 14.1 confirmed a Grade B postoperative pancreatic fistula (POPF). Given the patient’s baseline leukopenia and high susceptibility to secondary organ-space surgical site infection (SSI) from repeated laparotomies, the antimicrobial regimen was aggressively escalated to meropenem, tigecycline, and caspofungin. Targeted conservative management using subcutaneous octreotide (600 mcg/day) and a medium-chain triglyceride (MCT) diet achieved complete resolution of the fistula by POD 11 without requiring secondary invasive re-intervention. Following standard post-splenectomy immunizations (PCV13, MCV4, Hib), the patient was discharged symptom-free on POD 13. The post-discharge protocol mandated full therapeutic anticoagulation and dual antiplatelet therapy (aspirin and clopidogrel) for 3 months. An esophagogastroduodenoscopy (EGD) performed at 3 months documented complete eradication of all esophageal varices. Serial clinical, laboratory, and radiologic surveillance up to 1 year confirmed stable portal system patency, complete wound healing, and total resolution of this high-stakes vascular crisis. Figure 1.Preoperative radiological findings.(A) Coronal contrast-enhanced CT image demonstrating massive splenomegaly, with a spleen length of 20.8 cm. (B) Axial CTA image showing a superior mesenteric venous filling defect, consistent with thrombus. (C) Axial CT image revealing non-enhancement of the portal vein at the confluence, indicating thrombosis. Figure 2.Intraoperative findings and gross specimen.(A) Operative field view showing significant bleeding and extensive adhesions encountered during the initial dissection. (B) Resected splenic specimen with an initial weight exceeding 1 kg. (C) Gross specimen showing evidence of tight diaphragmatic, gastric, costal, pancreatic, and colonic adhesions (green arrows). Figure 3.H&E-stained section of the spleen (magnification: 100×) showing congestive splenomegaly with dilated veins and sinuses. Table 1Summary of relevant laboratory indices.RemarksResultReference valuesLaboratory testNormal hemoglobin15.26 g/dL14–18 g/dLHemoglobinLeucopenia2.597 × 10 /L4500–11 000/µLWhite Blood Cell Count (WBC) (4–10 × 10 /L):(Indicating severe thrombocytopenia & underlining hypersplenism).18.87 × 10 /L150 000– 450 000/µLPlatelets1.40.1−1.2 mg/dLBilirubin4.23.4–5.4 g/dLAlbumin3.9/ 1.510–14 sProthrombin time & INRAs there were no encephalopathy, no ascites and 1 point for each biochemical parameter, our case was Child-Pugh class 1. Preoperative radiological findings. Intraoperative findings and gross specimen. H&E-stained section of the spleen (magnification: 100×) showing congestive splenomegaly with dilated veins and sinuses. Table 1Summary of relevant laboratory indices.RemarksResultReference valuesLaboratory testNormal hemoglobin15.26 g/dL14–18 g/dLHemoglobinLeucopenia2.597 × 10 /L4500–11 000/µLWhite Blood Cell Count (WBC) (4–10 × 10 /L):(Indicating severe thrombocytopenia & underlining hypersplenism).18.87 × 10 /L150 000– 450 000/µLPlatelets1.40.1−1.2 mg/dLBilirubin4.23.4–5.4 g/dLAlbumin3.9/ 1.510–14 sProthrombin time & INRAs there were no encephalopathy, no ascites and 1 point for each biochemical parameter, our case was Child-Pugh class 1. Summary of relevant laboratory indices. As there were no encephalopathy, no ascites and 1 point for each biochemical parameter, our case was Child-Pugh class 1. Discussion Notably, a review of current literature revealed no prior reports of a similar clinical constellation involving mechanical bowel ischemia, PMVT, massive splenomegaly, schistosomal periportal fibrosis, severe thrombocytopenia, and portal hypertension occurring simultaneously. This unprecedented complexity underscores why an adaptable surgical approach and dedicated surgeon-led multidisciplinary collaboration were vital to achieving a successful outcome. In endemic regions, schistosomal periportal fibrosis is a leading primary etiology driving non-cirrhotic portal hypertension and subsequent congestive splenomegaly[11]. Characteristically, our patient presented with Child-Pugh Class A status, without baseline liver cirrhosis. Instead, his clinical course was acutely derailed by supervening PMVT and secondary bowel ischemia. While PMVT frequently exacerbates portal hypertension in chronic liver disease[12,13], its acute-on-chronic manifestation in non-cirrhotic schistosomal fibrosis creates a unique dilemma. Obstruction of the portal vein accelerates the development of extensive collateral pathways, exponentially increasing portal pressure and worsening splenomegaly[14]. This complex vascular architecture underscores the necessity of advanced imaging (Doppler ultrasound and CTA) to accurately delineate vascular occlusion and visceral compromise[12], which in this case demonstrated partial portal and SMV thrombosis driving downstream jejunal ischemia[15]. When patients with schistosomal massive splenomegaly present with acute abdominal pain, the differential diagnosis routinely prioritizes spontaneous splenic rupture, acute infarction, or variceal hemorrhage. Conversely, the acute manifestation of mechanical bowel ischemia in conjunction with PMVT is exceptionally rare. While hypersplenism itself – characterized by cellular sequestration[15] – does not cause mesenteric ischemia, the associated alterations in portomesenteric hemodynamics and local venous stasis drastically elevate spontaneous thrombotic risks[12,14], representing a highly atypical pattern of acute surgical presentation. The profound thrombocytopenia (<19.0 × 109/L) posed a catastrophic risk of hemorrhage, though the patient exhibited no active preoperative bleeding due to physiological adaptation[16]. Nevertheless, the critical need to salvage the bowel necessitated a splenectomy to decompress the portal system and relieve the severe hydrostatic backpressure contributing to bowel ischemia[12,14,16]. Executing an emergency massive splenectomy mandates meticulous hematological preparation; early, real-time consultation with a hematologist facilitated a safe operative course. Procedurally, massive splenectomy carries a high baseline risk of hemorrhage and diffuse venous oozing – secondary to vascularized perisplenic adhesiolysis – which aligns with standard documented complications[2,6,8,9,17]. Furthermore, the postoperative course was complicated by a Grade B pancreatic fistula, a technically predictable sequela when removing giant spleens[6]. Severe inflammatory adhesions heavily obscure the anatomical planes between the splenic hilum and the pancreatic tail, making inadvertent micro-trauma highly likely during surgical mobilization[16]. The favorable outcome achieved underscores the paramount importance of an adaptable, multi-staged surgical strategy integrated with a progressive, surgeon-led multidisciplinary team (MDT) paradigm. The surgeon successfully drove swift, collaborative decision-making in the ED to weigh immediate ischemic risks against active thrombocytopenia. Postoperatively, the clinical team was dynamically restructured; an intensivist and a clinical pharmacist navigated the critical 72-hour ICU window to optimize antimicrobial coverage, titrate octreotide, and manage parenteral nutrition. By POD 5, a clinical dietitian introduced a specialized medium-chain triglyceride (MCT) formula to promote jejunal recovery while down-regulating pancreatic exocrine secretions, successfully resolving the fistula. Ultimately, this case demonstrates that success in managing intricate surgical dilemmas hinges on a responsive, patient-centered team under clear surgical leadership[5]. Combined splenectomy and esophagogastric devascularization proved highly effective at reducing portal pressures and ensuring the eradication of esophageal varices[18]. In such complex portomesenteric pathologies, early thromboprophylaxis and timely surgeon-led intervention remain critical to optimizing emergency outcomes. Conclusion Emergent, advanced schistosomal periportal fibrosis requires an integrated surgical approach. Combining massive splenectomy with esophagogastric devascularization during acute laparotomy successfully resolves both urgent ischemic complications and chronic portal hypertension. This unified, surgeon-led strategy ensures safe recovery, reduces long-term variceal risks, and underscores the vital role of strategic damage control and MDT collaboration in critical emergencies.